Cargando…

Resource use and clinical outcomes in patients with atrial fibrillation with ablation versus antiarrhythmic drug treatment

BACKGROUND: The objective of our study was to compare resource use and clinical outcomes among atrial fibrillation (AF) patients who underwent catheter ablation versus antiarrhythmic drug (AAD) treatment. METHODS: A retrospective cohort design using the Clinical Practice Research Data-Hospital Episo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jarman, Julian W. E., Hussain, Wajid, Wong, Tom, Markides, Vias, March, Jamie, Goldstein, Laura, Liao, Ray, Kalsekar, Iftekhar, Chitnis, Abhishek, Khanna, Rahul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223058/ https://www.ncbi.nlm.nih.gov/pubmed/30404603 http://dx.doi.org/10.1186/s12872-018-0946-6

Ejemplares similares

Stroke rates before and after ablation of atrial fibrillation and in propensity-matched controls in the UK
por: Jarman, Julian WE, et al.
Publicado: (2017)

Mortality, stroke, and heart failure in atrial fibrillation cohorts after ablation versus propensity-matched cohorts
por: Jarman, Julian WE, et al.
Publicado: (2017)

Internationally validated score to predict the outcome of non-paroxysmal atrial fibrillation ablation: the ‘FLAME score’
por: Boyalla, Vennela, et al.
Publicado: (2021)

Beyond pulmonary vein isolation for persistent atrial fibrillation: sequential high-resolution mapping to guide ablation
por: Malaczynska-Rajpold, Katarzyna, et al.
Publicado: (2022)

Real-world outcomes comparison among adults with atrial fibrillation undergoing catheter ablation with a contact force porous tip catheter versus a second-generation cryoballoon catheter: a retrospective analysis of multihospital US database
por: Costea, Alexandru, et al.
Publicado: (2020)

Heart failure risk in patients with atrial fibrillation treated with catheter ablation vs antiarrhythmic drugs
por: Gruber, Megan, et al.
Publicado: (2023)

Comparison of real-world clinical and economic outcomes between the ThermoCool(®) SF and ThermoCool(®) catheters in patients undergoing radiofrequency catheter ablation for atrial fibrillation
por: Chinitz, Larry, et al.
Publicado: (2018)

Left Atrial Function Predicts Atrial Arrhythmia Recurrence Following Ablation of Long-Standing Persistent Atrial Fibrillation
por: Khan, Habib Rehman, et al.
Publicado: (2023)

Trends and predictors of early ablation for Atrial Fibrillation in a Nationwide population under age 65: a retrospective observational study
por: D’Angelo, Robert N., et al.
Publicado: (2020)

Catheter Ablation of Atrial Fibrillation in Patients With Functional Mitral Regurgitation and Left Ventricular Systolic Dysfunction
por: Wu, Jin-Tao, et al.
Publicado: (2020)

Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation
por: Winkle, Roger A., et al.
Publicado: (2012)

Knots to untie: anticoagulant and antiarrhythmic therapy after ablation for atrial fibrillation
por: Stazi, Filippo
Publicado: (2020)

Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs
por: Park, Yoon Jung, et al.
Publicado: (2023)

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

Position of Totally Thoracoscopic Surgical Ablation in the Treatment of Atrial Fibrillation: An Alternative Method of Conduction Testing
por: Sabashnikov, Anton, et al.
Publicado: (2015)

Atrial Tachycardias Arising from Ablation of Atrial Fibrillation: A Proarrhythmic Bump or an Antiarrhythmic Turn?
por: Shah, Ashok J., et al.
Publicado: (2010)

Catheter Ablation versus Thoracoscopic Surgical Ablation in Long Standing Persistent Atrial Fibrillation (CASA-AF): study protocol for a randomised controlled trial
por: Khan, Habib Rehman, et al.
Publicado: (2018)

Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation—Insights from the German Ablation Registry
por: Schleberger, Ruben, et al.
Publicado: (2021)

Meta‐analysis of cryoballoon ablation versus antiarrhythmic drugs as initial therapy for symptomatic atrial fibrillation
por: Mao, Yin‐jun, et al.
Publicado: (2021)

Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation
por: Kuniss, Malte, et al.
Publicado: (2021)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2018)

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2018)

RAAFT-2: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation
por: Kaba, Riyaz A, et al.
Publicado: (2014)

Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design
por: Packer, Douglas L., et al.
Publicado: (2018)

Ablation and antiarrhythmic drug effects on PITX2(+/−) deficient atrial fibrillation: A computational modeling study
por: Jin, Ze, et al.
Publicado: (2022)

Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial
por: Haldar, Shouvik, et al.
Publicado: (2020)

Catheter ablation for AF improves global thrombotic profile and enhances fibrinolysis
por: Niespialowska-Steuden, Maria, et al.
Publicado: (2017)

Relevance of electrical connectivity between the coronary sinus and the left atrial appendage for the intentional electrical isolation of the left atrial appendage in treating persistent atrial fibrillation: Insights from the LEIO-AF study
por: Ibrahim, Mokhtar, et al.
Publicado: (2018)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013)

Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
por: Hwang, Inseok, et al.
Publicado: (2021)

Healthcare utilization and cost in patients with atrial fibrillation and heart failure undergoing catheter ablation
por: Field, Michael E., et al.
Publicado: (2020)

Comparison of radiofrequency ablation and antiarrhythmic drug for the treatment of atrial fibrillation: A protocol for systematic review and meta-analysis
por: Deng, Junping, et al.
Publicado: (2022)

Atrial fibrillation and sympatho–vagal imbalance: from the choice of the antiarrhythmic treatment to patients with syncope and ganglionated plexi ablation
por: Rebecchi, Marco, et al.
Publicado: (2023)

Cost-effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation: A Canadian Perspective
por: Khaykin, Yaariv, et al.
Publicado: (2016)

Effect of repeat catheter ablation vs. antiarrhythmic drug therapy among patients with recurrent atrial tachycardia/atrial fibrillation after atrial fibrillation catheter ablation: data from CHINA-AF registry
por: Zhou, Lu, et al.
Publicado: (2022)

Blanking period antiarrhythmic drugs after catheter ablation for atrial fibrillation: a meta-analysis of randomized controlled trials
por: Chen, Gang, et al.
Publicado: (2023)

Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation
por: Wang, Amy
Publicado: (2012)

Time‐dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses
por: Carstensen, Helena, et al.
Publicado: (2018)

Corrigendum: Computational modeling for antiarrhythmic drugs for atrial fibrillation according to genotype
por: Hwang, Inseok, et al.
Publicado: (2022)

Association between specific antiarrhythmic drug prescription in the post-procedural blanking period and recurrent atrial arrhythmias after catheter ablation for atrial fibrillation
por: Malladi, Chaitanya L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fadbao1lncp43ef1mclcjs1l8v